TipRanks
Go Ultimate55% OFF

Comparison Results

Comparison results
NamePricePrice ChangePrice TargetSmart ScoreExpense RatioAsset Under ManagementFollow
BISProShares UltraShort Nasdaq Biotechnology$10.47―0.95%1.73M
XLVHealth Care Select Sector SPDR Fund$184.87$196.19(6.13% Upside)0.08%48.89B
PBPHPortfolio Building Block World Pharma and Biotech Index ETF$31.35$32.90(4.96% Upside)0.13%1.17B
CANCTema Oncology ETF$42.29$60.99(44.23% Upside)0.75%216.18M
LFSCF/M Emerald Life Sciences Innovation ETF$43.60$66.87(53.38% Upside)0.54%125.43M
IBBQInvesco Nasdaq Biotechnology ETF$36.17$45.87(26.80% Upside)0.19%120.43M
HRTSTema Cardiovascular and Metabolic ETF$38.87$45.45(16.93% Upside)0.75%57.10M
OZEMRoundhill GLP-1 & Weight Loss ETF$30.70$48.04(56.51% Upside)0.59%55.57M
PSILAdvisorShares Psychedelics ETF$21.00$55.08(162.26% Upside)1.00%46.62M

International Listings

OTC and non-US listings of funds similar to BIB.

Comparison results
NamePricePrice ChangePrice TargetSmart ScoreExpense RatioAsset Under ManagementFollow
IVBUFiShares NASDAQ US Biotechnology UCITS ETF$10.67$13.60(27.50% Upside)0.37%1.26B

Performance Comparison

-50%-25%0%25%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
BISProShares UltraShort Nasdaq Biotechnology10.47-10.94-51.10%
XLVHealth Care Select Sector SPDR Fund184.8742.8030.12%
PBPHPortfolio Building Block World Pharma and Biotech Index ETF31.356.3025.14%
CANCTema Oncology ETF42.2911.6538.04%
LFSCF/M Emerald Life Sciences Innovation ETF43.6011.3135.02%
IBBQInvesco Nasdaq Biotechnology ETF36.1710.1138.81%
HRTSTema Cardiovascular and Metabolic ETF38.876.9621.81%
OZEMRoundhill GLP-1 & Weight Loss ETF30.702.027.03%
PSILAdvisorShares Psychedelics ETF21.003.7721.91%

ETFs Similar to BIB FAQ

What is the cheapest alternative to BIB?
Among the ETFs similar to BIB, XLV (Health Care Select Sector SPDR Fund) has the lowest expense ratio, at 0.08% a year, compared with 0.95% for BIB.
BIB vs. BIS: what is the difference?
BIS (ProShares UltraShort Nasdaq Biotechnology) is the first ETF in BIB's similar-ETF list. It has $1.73M in assets under management and a 0.95% expense ratio, against $103.75M and 0.95% for BIB. Compare their performance, price targets and Smart Scores in the table above.